內部人士可能會獲得普通股東無法享受的可觀財務利益。
擬議的交易可能包含限制更優競爭報價的條款。
鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或承擔任何義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或開支。
, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否可能違反聯邦證券法和/或對股東的信託責任：
Kennedy-Wilson Holdings, Inc. (NYSE: KW) 以每股 10.90 美元現金出售給由 Kennedy-Wilson 董事長兼首席執行官 William McMorrow 及其他一些高級管理人員和 Fairfax Financial Holdings Limited 組成的財團。如果您是 Kennedy-Wilson 的股東， 請點擊這裏瞭解您的權利和選擇 。
Barinthus Biotherapeutics plc (NASDAQ: BRNS) 與 Clywedog Therapeutics, Inc.的合併。根據協議條款，Barinthus 的股東將根據其持有的每一份美國存托股票或普通股獲得新合併公司的一股普通股。如果您是 Barinthus 的股東， 請點擊這裏瞭解您的權利和選擇 。
Affinity Bancshares, Inc. (NASDAQ: AFBI) 以每股 23.00 美元現金出售給 Fidelity BancShares (N.C.)，該價格將根據 Affinity 在交割時的調整後股東權益進行調整。如果您是 Affinity 的股東， 請點擊這裏瞭解您的法律權利和選擇。
Halper Sadeh LLC 可能代表股東尋求增加對價、額外披露和信息，或其他救濟和利益。
Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
律師廣告。以往的結果並不保證類似的結果。
聯繫信息：
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
世界貿易中心一號
85 層
紐約，NY 10007
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
來源 Halper Sadeh LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4"/>

BRNS

Kennedy-Wilson控股

AFBI

Halper Sadeh LLC 正在調查 Kennedy-Wilson Holdings、Barinthus Biotherapeutics 和 Affinity Bancshares 是否存在潛在的聯邦證券法違規和違反受託責任的行為。該公司擔心內部人士可能會在普通股東的利益受損的情況下獲得財務利益。股東們被鼓勵聯繫該公司，以瞭解有關擬議交易的法律權利和選擇，這些交易包括以每股 10.90 美元出售 Kennedy-Wilson、涉及 Barinthus 的合併，以及以每股 23.00 美元出售 Affinity

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
<div class="lb-trans">內部人士可能會獲得普通股東無法享受的可觀財務利益。
</div>The proposed transactions may contain terms that could limit superior competing offers.
<div class="lb-trans">擬議的交易可能包含限制更優競爭報價的條款。
</div>Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
<div class="lb-trans">鼓勵股東與本公司聯繫，討論他們的權利和選擇，且無需支付任何費用或承擔任何義務。我們將以風險代理的方式處理任何事務，您無需承擔我們的法律費用或開支。
</div>, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
<div class="lb-trans">, /PRNewswire/ -- Halper Sadeh LLC，一家投資者權益法律事務所，正在調查以下公司是否可能違反聯邦證券法和/或對股東的信託責任：
</div>Kennedy-Wilson Holdings, Inc. (NYSE: KW)'s sale to consortium led by William McMorrow, Chairman and Chief Executive Officer of Kennedy-Wilson, and certain other senior executives of Kennedy-Wilson, together with Fairfax Financial Holdings Limited, for $10.90 per share in cash. If you are a Kennedy-Wilson shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Kennedy-Wilson Holdings, Inc. (NYSE: KW) 以每股 10.90 美元現金出售給由 Kennedy-Wilson 董事長兼首席執行官 William McMorrow 及其他一些高級管理人員和 Fairfax Financial Holdings Limited 組成的財團。如果您是 Kennedy-Wilson 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>Barinthus Biotherapeutics plc (NASDAQ: BRNS)'s merger with Clywedog Therapeutics, Inc. Under the terms of the agreement, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. If you are a Barinthus shareholder, click here to learn more about your rights and options .
<div class="lb-trans">Barinthus Biotherapeutics plc (NASDAQ: BRNS) 與 Clywedog Therapeutics, Inc.的合併。根據協議條款，Barinthus 的股東將根據其持有的每一份美國存托股票或普通股獲得新合併公司的一股普通股。如果您是 Barinthus 的股東， 請點擊這裏瞭解您的權利和選擇 。
</div>Affinity Bancshares, Inc. (NASDAQ: AFBI)'s sale to Fidelity BancShares (N.C.), Inc. for $23.00 per share in cash, subject to adjustment based on Affinity's adjusted stockholders' equity at closing. If you are an Affinity shareholder, click here to learn more about your legal rights and options.
<div class="lb-trans">Affinity Bancshares, Inc. (NASDAQ: AFBI) 以每股 23.00 美元現金出售給 Fidelity BancShares (N.C.)，該價格將根據 Affinity 在交割時的調整後股東權益進行調整。如果您是 Affinity 的股東， 請點擊這裏瞭解您的法律權利和選擇。
</div>On behalf of shareholders, Halper Sadeh LLC may seek increased consideration, additional disclosures and information, or other relief and benefits.
<div class="lb-trans">Halper Sadeh LLC 可能代表股東尋求增加對價、額外披露和信息，或其他救濟和利益。
</div>Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
<div class="lb-trans">Halper Sadeh LLC 代表全球受證券欺詐和公司不當行為影響的投資者。我們的律師在實施公司改革和為受欺詐投資者追回數百萬美元方面發揮了重要作用。
</div>Attorney Advertising. Prior results do not guarantee a similar outcome.
<div class="lb-trans">律師廣告。以往的結果並不保證類似的結果。
</div>Contact Information:
<div class="lb-trans">聯繫信息：
</div>Halper Sadeh LLC
<div class="lb-trans">Halper Sadeh LLC
</div>Daniel Sadeh, Esq.
<div class="lb-trans">Daniel Sadeh, Esq.
</div>Zachary Halper, Esq.
<div class="lb-trans">Zachary Halper, Esq.
</div>One World Trade Center
<div class="lb-trans">世界貿易中心一號
</div>85th Floor
<div class="lb-trans">85 層
</div>New York, NY 10007
<div class="lb-trans">紐約，NY 10007
</div>(212) 763-0060
<div class="lb-trans">(212) 763-0060
</div>[email protected]
<div class="lb-trans">[email protected]
</div>[email protected]
<div class="lb-trans">[email protected]
</div>https://www.halpersadeh.com
<div class="lb-trans">https://www.halpersadeh.com
</div>SOURCE Halper Sadeh LLP
<div class="lb-trans">來源 Halper Sadeh LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwNTEyJk5ld3NJdGVtSWQ9Tlk1NzA2OCZUcmFuc21pc3Npb25fSWQ9MjAyNjA1MTIwMjU0UFJfTkVXU19VU1BSX19fX19OWTU3MDY4" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=NY57068&amp;Transmission_Id=202605120254PR_NEWS_USPR_____NY57068&amp;DateId=20260512"/>

Kennedy-Wilson 控股、Barinthus Biotherapeutics 和 Affinity Bancshares 是否為其股東爭取到了公平的交易？